We serve Chemical Name:Lophanthoidin E CAS:120462-45-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Lophanthoidin E
CAS.NO:120462-45-5
Synonyms:(6β,7α)-6,7,12-Trihydroxy-11,14-dioxoabieta-8,12-dien-16-yl acetate;1,4-Phenanthrenedione, 2-[2-(acetyloxy)-1-methylethyl]-4b,5,6,7,8,8a,9,10-octahydro-3,9,10-trihydroxy-4b,8,8-trimethyl-, (4bS,8aS,9S,10S)-
Molecular Formula:C22H30O7
Molecular Weight:406.469
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:551.3±50.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.577
PSA:121.13000
Exact Mass:406.199158
LogP:4.34
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (6β,7α)-6,7,12-Trihydroxy-11,14-dioxoabieta-8,12-dien-16-yl acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Phenanthrenedione, 2-[2-(acetyloxy)-1-methylethyl]-4b,5,6,7,8,8a,9,10-octahydro-3,9,10-trihydroxy-4b,8,8-trimethyl-, (4bS,8aS,9S,10S)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Phenanthrenedione, 2-[2-(acetyloxy)-1-methylethyl]-4b,5,6,7,8,8a,9,10-octahydro-3,9,10-trihydroxy-4b,8,8-trimethyl-, (4bS,8aS,9S,10S)- Use and application,(6β,7α)-6,7,12-Trihydroxy-11,14-dioxoabieta-8,12-dien-16-yl acetate technical grade,usp/ep/jp grade.
Related News: The company’s greenfield facility in Vasanthnarsapura Karnataka Industrial Area, Tumkur district, Karnataka, is under construction and is expected to be commissioned by April, 2022, well before the PLI scheme deadline of April 1, 2023. 2,3-dichloro-6-(trifluoromethyl)benzaldehyde manufacturers As for argenx’s efgartigimod, that drug hasn’t scored an FDA nod yet and its eventual cost-effectiveness will depend on its price. 4-bromotetrafluorophenylhydrazine suppliers The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. 5,7-Dimethyl-1H-pyrrolo[2,3-c]pyridine vendor & factory.